IL162079A0 - 3,4-Disubstituted, 3,5-disubstituted and substituted and 3,4,5-substituted piperidines and piperazines - Google Patents
3,4-Disubstituted, 3,5-disubstituted and substituted and 3,4,5-substituted piperidines and piperazinesInfo
- Publication number
- IL162079A0 IL162079A0 IL16207902A IL16207902A IL162079A0 IL 162079 A0 IL162079 A0 IL 162079A0 IL 16207902 A IL16207902 A IL 16207902A IL 16207902 A IL16207902 A IL 16207902A IL 162079 A0 IL162079 A0 IL 162079A0
- Authority
- IL
- Israel
- Prior art keywords
- disubstituted
- substituted
- piperazines
- piperidines
- substituted piperidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33270801P | 2001-11-19 | 2001-11-19 | |
US38316702P | 2002-05-24 | 2002-05-24 | |
PCT/US2002/037037 WO2003043987A2 (en) | 2001-11-19 | 2002-11-19 | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162079A0 true IL162079A0 (en) | 2005-11-20 |
Family
ID=26988352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16207902A IL162079A0 (en) | 2001-11-19 | 2002-11-19 | 3,4-Disubstituted, 3,5-disubstituted and substituted and 3,4,5-substituted piperidines and piperazines |
Country Status (21)
Country | Link |
---|---|
US (1) | US7338965B2 (hr) |
EP (1) | EP1448200A2 (hr) |
JP (1) | JP2005514362A (hr) |
KR (1) | KR20050044533A (hr) |
AP (1) | AP2004003052A0 (hr) |
AU (1) | AU2002360403A1 (hr) |
BR (1) | BR0214295A (hr) |
CA (1) | CA2467749A1 (hr) |
CO (1) | CO5580743A2 (hr) |
EA (1) | EA200400699A1 (hr) |
GE (1) | GEP20074045B (hr) |
HR (1) | HRP20040550A2 (hr) |
IL (1) | IL162079A0 (hr) |
IS (1) | IS7271A (hr) |
MX (1) | MXPA04004772A (hr) |
NO (1) | NO20042580L (hr) |
NZ (1) | NZ533158A (hr) |
OA (1) | OA12812A (hr) |
RS (1) | RS54204A (hr) |
TN (1) | TNSN04088A1 (hr) |
WO (1) | WO2003043987A2 (hr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
WO2006110668A1 (en) | 2005-04-08 | 2006-10-19 | Comentis, Inc. | Compounds which inhibit beta-secretase activity and methods of use thereof |
EP1816122A3 (en) * | 2006-01-19 | 2007-09-19 | Speedel Experimenta AG | 3,4,5-substituted piperidines as therapeutic compounds |
US8216582B2 (en) | 2006-06-23 | 2012-07-10 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in cancer |
KR100679869B1 (ko) * | 2006-10-27 | 2007-02-07 | 한국기계연구원 | Dpf시스템용 플라즈마 반응기와 이를 이용한 입자상물질의 저감 장치 |
AU2007297627A1 (en) * | 2006-09-21 | 2008-03-27 | Merck Sharp & Dohme Corp. | Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
KR100838645B1 (ko) * | 2006-09-28 | 2008-06-16 | 한국화학연구원 | 베타-세크리테아제 활성을 억제하는 피페리딘 화합물 |
JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体 |
ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
NZ579310A (en) | 2007-03-01 | 2012-03-30 | Probiodrug Ag | Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof |
DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
KR100894713B1 (ko) * | 2007-10-08 | 2009-04-24 | 한국화학연구원 | 베타-세크리테아제의 활성을 저해하는 아릴피페라진이 치환된 피페리딘 유도체 또는 이의 약제학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 신경퇴행성 질환의 예방 또는 치료용 조성물 |
MX336869B (es) | 2008-11-03 | 2016-02-04 | Alethia Biotherapeutics Inc | Anticuerpos que bloquean espicificamente la actividad biologica de un antigeno de tumor. |
US8486940B2 (en) | 2009-09-11 | 2013-07-16 | Probiodrug Ag | Inhibitors |
EP2542549B1 (en) | 2010-03-03 | 2016-05-11 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
BR112012022478B1 (pt) | 2010-03-10 | 2021-09-21 | Probiodrug Ag | Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica |
US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
PL3173427T3 (pl) | 2011-03-31 | 2019-11-29 | Adc Therapeutics Sa | Przeciwciała przeciwko antygenowi związanemu z nerkami 1 i ich fragmenty wiążące antygen |
PT2802351T (pt) | 2012-01-09 | 2019-06-27 | Adc Therapeutics Sa | Agentes para o tratamento de cancro da mama triplo negativo |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992441A (en) * | 1972-12-26 | 1976-11-16 | Pfizer Inc. | Sulfamylbenzoic acids |
US4248876A (en) * | 1977-01-08 | 1981-02-03 | John Wyeth & Brother Ltd. | Piperidine derivatives |
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
DE3640475A1 (de) * | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
US4997836A (en) * | 1988-11-11 | 1991-03-05 | Takeda Chemical Industries, Ltd. | Trisubstituted piperazine compounds, their production and use |
US5510378A (en) * | 1990-11-19 | 1996-04-23 | G.D. Searle & Co. | Retroviral protease inhibitors |
KR100336699B1 (ko) * | 1992-08-25 | 2002-05-13 | 윌리암스 로저 에이 | 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드 |
US5475138A (en) * | 1994-07-07 | 1995-12-12 | Pharm-Eco Laboratories Incorporated | Method preparing amino acid-derived diaminopropanols |
WO1997009311A1 (de) * | 1995-09-07 | 1997-03-13 | F. Hoffmann-La Roche Ag | Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz |
ATE287402T1 (de) | 1997-02-04 | 2005-02-15 | Univ California | Nanomolare, non-peptidische inhibitoren von cathepsin d |
WO1999012532A2 (en) * | 1997-09-08 | 1999-03-18 | F.Hoffmann-La Roche Ag | Piperidine derivatives against malaria |
DK1034174T3 (da) * | 1997-11-05 | 2003-09-22 | Neurosearch As | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer |
HUP0101320A3 (en) * | 1998-01-21 | 2002-11-28 | Kyowa Hakko Kogyo Kk | Benzo- and pyridobenzoxepine and -benzazepine derivatives and use thereof |
GB9810671D0 (en) * | 1998-05-18 | 1998-07-15 | Pfizer Ltd | Anti-pruritic agents |
BR9912013A (pt) * | 1998-07-10 | 2001-04-10 | Astrazeneca Ab | Composto, composição farmacêutica, método de tratar uma condição de doença, e, processo para preparar um composto |
US6274735B1 (en) * | 1998-08-10 | 2001-08-14 | Hoffmann-La Roche Inc. | Process and intermediates for preparation of substituted piperidines |
CA2346537A1 (en) * | 1998-10-07 | 2000-04-13 | Gian Luca Araldi | Monomeric and dimeric heterocycles, and therapeutic uses thereof |
GB9904786D0 (en) * | 1999-03-02 | 1999-04-28 | Merck Sharp & Dohme | Therapeutic agents |
EP1361875A2 (en) * | 2001-02-16 | 2003-11-19 | Aventis Pharmaceuticals Inc. | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
US20060079533A1 (en) * | 2001-03-23 | 2006-04-13 | Nieman James A | Methods of treating alzheimer's disease |
JP2004534017A (ja) * | 2001-04-27 | 2004-11-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | Baceのインヒビター |
-
2002
- 2002-11-19 WO PCT/US2002/037037 patent/WO2003043987A2/en active Application Filing
- 2002-11-19 IL IL16207902A patent/IL162079A0/xx unknown
- 2002-11-19 MX MXPA04004772A patent/MXPA04004772A/es not_active Application Discontinuation
- 2002-11-19 US US10/299,746 patent/US7338965B2/en not_active Expired - Fee Related
- 2002-11-19 OA OA1200400289A patent/OA12812A/en unknown
- 2002-11-19 CA CA002467749A patent/CA2467749A1/en not_active Abandoned
- 2002-11-19 JP JP2003545624A patent/JP2005514362A/ja active Pending
- 2002-11-19 EP EP02795653A patent/EP1448200A2/en not_active Withdrawn
- 2002-11-19 NZ NZ533158A patent/NZ533158A/en unknown
- 2002-11-19 GE GE5634A patent/GEP20074045B/en unknown
- 2002-11-19 BR BR0214295-3A patent/BR0214295A/pt not_active IP Right Cessation
- 2002-11-19 RS YU54204A patent/RS54204A/sr unknown
- 2002-11-19 KR KR1020047007631A patent/KR20050044533A/ko not_active Application Discontinuation
- 2002-11-19 AU AU2002360403A patent/AU2002360403A1/en not_active Abandoned
- 2002-11-19 AP APAP/P/2004/003052A patent/AP2004003052A0/en unknown
- 2002-11-19 EA EA200400699A patent/EA200400699A1/ru unknown
-
2004
- 2004-05-19 TN TNP2004000088A patent/TNSN04088A1/en unknown
- 2004-05-19 IS IS7271A patent/IS7271A/is unknown
- 2004-05-26 CO CO04048699A patent/CO5580743A2/es not_active Application Discontinuation
- 2004-06-16 HR HR20040550A patent/HRP20040550A2/xx not_active Application Discontinuation
- 2004-06-18 NO NO20042580A patent/NO20042580L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IS7271A (is) | 2004-05-19 |
MXPA04004772A (es) | 2005-06-06 |
NO20042580L (no) | 2004-08-09 |
AU2002360403A1 (en) | 2003-06-10 |
EA200400699A1 (ru) | 2004-12-30 |
HRP20040550A2 (en) | 2006-11-30 |
AP2004003052A0 (en) | 2004-06-30 |
GEP20074045B (en) | 2007-02-26 |
WO2003043987A3 (en) | 2003-07-10 |
KR20050044533A (ko) | 2005-05-12 |
RS54204A (en) | 2006-12-15 |
OA12812A (en) | 2006-07-10 |
CA2467749A1 (en) | 2003-05-30 |
TNSN04088A1 (en) | 2006-06-01 |
US20040034031A1 (en) | 2004-02-19 |
WO2003043987A2 (en) | 2003-05-30 |
CO5580743A2 (es) | 2005-11-30 |
JP2005514362A (ja) | 2005-05-19 |
NZ533158A (en) | 2006-09-29 |
US7338965B2 (en) | 2008-03-04 |
BR0214295A (pt) | 2004-11-09 |
EP1448200A2 (en) | 2004-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL162079A0 (en) | 3,4-Disubstituted, 3,5-disubstituted and substituted and 3,4,5-substituted piperidines and piperazines | |
AU3740101A (en) | 2,4-disubstituted thiazolyl derivatives | |
MXPA03009000A (es) | Compuestos benzo-fusionados 1,4-disustituidos. | |
DE60220778D1 (en) | 3,4-disubstituierte cyclobuten-1,2-dione als cxc-chemokinrezeptorliganden | |
ZA99314B (en) | 4-(2-Keto-1-Benzimidazolinyl)piperidine compounds as orl1-receptor agonists. | |
IL162377A0 (en) | 5,6-Diaryl-pyrazine-2-amide derivatives as cb1 antagonists | |
NO20033165D0 (no) | (+)-1-(3,4-diklorfenyl)-3-azabicyklo[3.1.0]heksan, sammensetning og anvendelse derav | |
GB2361235B (en) | 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides | |
IL150550A0 (en) | 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists | |
HK1039489A1 (en) | New piperazine and piperidine compounds. | |
EE200100498A (et) | 1,4-asendatud piperasiin-, 1,4-asendatud piperidiin- ja 1-asendatud 4-alkülidenüülpiperidiinühendidning nende raviotstarbeline kasutamine | |
MXPA03006991A (es) | Derivados de piperidina como antagonistas de neurocinina 1. | |
HK1055952A1 (en) | Piperazine an piperidine compounds. | |
HK1077296A1 (en) | 2,5-Disubstituted 3-mercaptopentanoic acid | |
AU2231502A (en) | 1,4-disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers | |
WO2002046156A3 (en) | 4,4-DISUBSTITUTED PIPERIDINES AND THEIR METHODS OF USE | |
TR199902839A3 (tr) | Yeni 4-ikameli piperidinler. | |
IL154675A0 (en) | N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide | |
GB0113342D0 (en) | Novel Heterocycles 1 | |
AU1018801A (en) | Use of 3,4-substituted piperidines | |
DK1315700T3 (da) | Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner | |
GB0113344D0 (en) | Novel heterocycles 3 | |
GB0113343D0 (en) | Novel Heterocycles 2 | |
PT1497256E (pt) | Compostos de 1,5-diaminopentan-3-ol substituídos | |
SI1532111T1 (sl) | 2,5disubstituirana 3-merkaptopentanojska kislina |